S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)
Status:
Terminated
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy such as docetaxel use different ways to stop tumor
cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of docetaxel in treating patients who have
locally advanced or metastatic penile cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Southwest Oncology Group
Collaborators:
Eastern Cooperative Oncology Group National Cancer Institute (NCI)